June 21, 2022 $1.1 Million in Price Transparency Fines to 2 Hospitals June 17, 2022 The Challenges of Reducing Clinicians’ Administrative Burdens June 3, 2022 Preserving Access to Telehealth: Today’s Policy Agenda of the American Telemedicine Association ...
医疗保险和医疗补助服务中心(CMS)于9月对两家医院处以罚款,原因是它们涉嫌违反其价格透明度规则。这标志着该机构在长达数年的轻度执法之后,连续第三个月对不遵守价格透明度规定的医院开出罚款。 9月5日发布的两项罚款是CMS对医院违反价格透明度规定的第十三项和第十四项处罚。华盛顿特区的圣伊丽莎白医院被罚款677440...
“It seems clear that CMS has doubled and tripled down on all things price transparency, including monitoring what hospital are doing, and is going to continue layering on requirements,” says Shah. “Simply doing the bare minimum, or being ready to pay the fine and calling ...
These policies will take effect 1 January 2022.Hospital Price TransparencyAs we had discussed in a prior client alert addressing the price transparency provisions in the OPPS Proposed Rule, CMS had proposed to significantly increase financial penalties on hospitals for ...
"DTRs" means the Disclosure Guidance and Transparency Rules published by the FCA; "Dowgate/Dowgate-RelatedParties" means Dowgate, David Poutney, Vivienne Poutney, Alice Poutney Wall, Madeleine Poutney, James Serjeant, Dr Jonathan Serjeant, Brenda McKenzie, Peter McKenzie, Paul Richards, Sherron ...
Thomas N. Bulleit Retired Partner +1 202 508 4600 contactus@ropesgray.com Podcast Health Care Transaction Laws Unwrapped: Recent Developments on the East Coast Alert New York State Adopts New Cybersecurity Program and Incident Reporting Requirements for Hospitals ...
CMS has released its strategy for health equity for all of its centers and offices including Medicare, Medicaid, and CHIP.
ending on or after January 1, 2021. CMS said the negotiated charges hospitals use to calculate the medians would be the negotiated charges for service packages that hospitals are already required to make public under the Hospital Price Transparency Final Rule that can be cross-walked to an MS...
The Proposed Rule, released on July 10, 2024, includes policies that aim to address health disparities, expand access to behavioral healthcare services and improve transparency in the health system, objectives that have been prioritized in prior OPPS rulemaking. CMS also issued requests for inf...
— The Discounted Drugs for Clinical Trials Act, which would allow researchers to buy expensive drugs or biologic products at the price it costs to manufacture them — The Pharmaceutical Research and Transparency Act of 2022, which would increase transparency in the costs of clinical trials,...